Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · IEX Real-Time Price · USD
2.160
+0.020 (0.93%)
Jul 2, 2024, 4:30 PM EDT - Market closed
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $34.18 million as of July 2, 2024. Its market cap has increased by 13.93% in one year.
Market Cap
34.18M
Enterprise Value
25.26M
1-Year Change
13.93%
Ranking
Category
Stock Price
$2.16
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $34.18M, a decrease of -40.30%. That is a compound annual growth rate of -15.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 33.90M | -35.67% |
| Dec 29, 2023 | 52.70M | 14.32% |
| Dec 30, 2022 | 46.10M | 4.54% |
| Dec 31, 2021 | 44.10M | -22.97% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cyclo Therapeutics | 36.34M |
| Aadi Bioscience | 35.85M |
| Precision Optics Corporation | 35.84M |
| Concord Medical Services Holdings | 35.82M |
| DarioHealth | 35.61M |
| IceCure Medical | 35.48M |
| IRIDEX | 35.11M |
| Surrozen | 35.03M |